Wearable Focal Vibration Therapy for Multiple Sclerosis

This trial tests a new home-based therapy called Wearable Focal Vibration Therapy to help people with multiple sclerosis (MS) improve arm function. The therapy uses a wearable device that sends gentle vibrations to arm muscles. The goal is to determine if this treatment can make arm movements easier and less painful. People with relapsing-remitting MS who have trouble using their arms or hands and haven't experienced an MS flare-up in the last six months are suitable candidates for this study. Participants will try the therapy for four weeks and share their experiences. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to experience this innovative therapy.

No, you can continue taking your current medications during the study as long as your treatment has been stable for at least four weeks before joining the trial.

Earlier studies have found wearable Focal Vibration Therapy (FVT) to be safe and easy to tolerate. Research shows that similar vibration therapies are simple to use and have few side effects. For instance, one study demonstrated that wearable FVT improved mobility in people with multiple sclerosis without causing serious problems. Participants in these studies reported the therapy as comfortable and easy to use.

Wearable Focal Vibration Therapy is unique because it offers a non-invasive approach to managing symptoms of Multiple Sclerosis (MS). Unlike traditional treatments, which often include medications like interferons or oral drugs that modulate the immune system, this therapy uses targeted vibrations to potentially improve muscle function and reduce spasticity. Researchers are excited about this therapy because it represents a new delivery method that could complement or even reduce the need for pharmaceutical interventions, offering a more straightforward and potentially side-effect-free option for patients.

Research shows that wearable Focal Vibration Therapy (FVT), which participants in this trial will receive, might help people with multiple sclerosis (MS) move better and feel less muscle stiffness. Studies have found that FVT can improve walking and movement in people with MS, suggesting it might also aid upper body use. Early evidence indicates it can reduce muscle tightness and weakness, making it easier for patients to use their arms and hands. Although more research is needed, these initial findings are promising for improving the quality of life for those with MS.¹⁵⁶⁷⁸